Business Context and Reporting Period
This Form 8-K is filed by BioSig Technologies, Inc. (BSGM), a Delaware corporation, reporting an event that occurred on July 5, 2019. The company is listed on the NASDAQ Capital Market and is designated as an emerging growth company.
Key Financial Metrics
The filing reports a specific cash inflow resulting from a warrant exercise:
- Cash Proceeds: $945,000 received from the Mayo Foundation for Medical Education and Research.
- Shares Issued: 252,000 shares of common stock.
- Exercise Price: $3.75 per share.
The filing text does not provide clear values for total revenue, net profit, operating margins, total debt, or overall liquidity positions for the reporting period.
Material Changes
The material change reported is the exercise of a warrant issued to the Mayo Clinic under a know-how license agreement dated March 15, 2017. This transaction resulted in the issuance of new shares and an immediate increase in cash assets of $945,000.
Outlook, Risks, and Management Commentary
The filing contains no forward-looking guidance, management commentary on future operations, or discussion of new risks or contingencies beyond the execution of the warrant. The warrant had an expiration date of March 15, 2020.
Investor Verification Checklist
- Verify the impact of the 252,000 new shares on total outstanding share count and potential dilution.
- Confirm the current cash balance and liquidity position following the $945,000 inflow.
- Review the terms of the March 15, 2017 know-how license agreement with the Mayo Clinic for any ongoing obligations.
- Check for any subsequent filings regarding the use of proceeds from this warrant exercise.